Does LAPATINIB DITOSYLATE Cause Peripheral swelling? 69 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Peripheral swelling have been filed in association with LAPATINIB DITOSYLATE (Lapatinib). This represents 1.8% of all adverse event reports for LAPATINIB DITOSYLATE.
69
Reports of Peripheral swelling with LAPATINIB DITOSYLATE
1.8%
of all LAPATINIB DITOSYLATE reports
5
Deaths
14
Hospitalizations
How Dangerous Is Peripheral swelling From LAPATINIB DITOSYLATE?
Of the 69 reports, 5 (7.2%) resulted in death, 14 (20.3%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAPATINIB DITOSYLATE. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does LAPATINIB DITOSYLATE Cause?
Diarrhoea (893)
Death (665)
Nausea (317)
Fatigue (301)
Vomiting (259)
Rash (249)
Drug ineffective (183)
Malignant neoplasm progression (183)
Off label use (141)
Disease progression (137)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which LAPATINIB DITOSYLATE Alternatives Have Lower Peripheral swelling Risk?
LAPATINIB DITOSYLATE vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
LAPATINIB DITOSYLATE vs LARONIDASE
LAPATINIB DITOSYLATE vs LAROTRECTINIB
LAPATINIB DITOSYLATE vs LASILIX
LAPATINIB DITOSYLATE vs LASIX